Skip to content ↓

Nader criticizes bio-patents in Green Party speech

Activist Ralph Nader brought his view of American society to MIT Monday night in a talk sponsored by MIT Greens and the Green Party.

Mr. Nader, the Green Party's US presidential candidate, was introduced Monday night at Wong Auditorium by Professor Jonathan King of biology, who shares a common interest in biogenetics with Mr. Nader.

"Are we ready to have Monsanto own our future?" Mr. Nader asked, decrying the patenting by private companies of biological information and materials. He argued that corporate science is overwhelming science itself, skewing the priorities of pharmaceutical research, for example, toward "lifestyle" drugs rather than remedies for massive worldwide health problems like malaria. He warned against proprietary data agreements that restrict the free exchange of ideas.

Despite unprecedented prosperity, he said, many Americans work for years without accumulating wealth. "We have a government of the Exxons, by the General Motors, and for the DuPonts. The people who really produce anything are the least paid. Some day, we're going to hear from the poor in this country," he said.

Mr. Nader said his interest in consumerism and quest for social justice was sparked while a law school student in the 1950s, in reaction to what he perceived to be the contented outlook of his fellow students and professors. "The word justice was almost never used at Harvard Law School," he said.

He noted that Jay Leno and his partners in irony on TV and in journalism had created an unhealthy atmosphere where the public had developed "a protective detachment from politics."

About two-thirds of the 225 people in the audience identified themselves as members of the MIT community.

A version of this article appeared in MIT Tech Talk on May 17, 2000.

Related Topics

More MIT News

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story